The purpose of this article is to, first, describe the content of a folic acid professional education intervention that was developed and implemented as a result of a collaborative effort between an academic institution and a nonprofit organization—the Pittsburgh, Pennsylvania, chapter of the March of Dimes—and the process by which it was developed; second, report the results of an evaluation of the impact of this intervention on knowledge and recommendation behaviors of health care providers; and third, discuss the implications for professional practice and continuing education. We developed a novel presentation that had practical utility for practitioners that could be implemented in either a classroom or continuing education setting.
Alaimo, K., McDowell, M. A., Briefel, R. R., Bischof, A. M., Caughman, C. R., Loria, C. M., et al. (1994). Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91(Advance Data No. 258). Hyattsville, MD: National Center for Health Statistics.
2.
Berry, R. J., Li, Z., Erickson, J. D., Li, S., Moore, C. A., Wang, H., et al. (1999). Prevention of neural tube defects with folic acid in China. New England Journal of Medicine, 341, 1485-1490.
3.
Bower, C., & Stanley, F. J. (1989). Dietary folate as a risk factor for neural tube defects: Evidence from a case-control study in Western Australia. Medical Journal of Australia, 150, 613-619.
4.
Brown, J. E., Jacobs, D. R., Hartman, T. J., Barosso, G. M., Stang, J. S., Gross, M. D., et al. (1997). Predictors of red cell folate level in women attempting pregnancy. Journal of the American Medical Association, 277(7), 548-552.
5.
Centers for Disease Control and Prevention. (1999). Knowledge and use of folic acid by women of child bearing age—US, 1995 and 1998. Journal of the American Medical Assocation, 281(20), 1883-1884.
6.
Cragan, J. D., Roberts, H. E., Edmonds, L. D., Khoury, M. J., Kirby, R., S., Shaw, G. M., et al. (1995). Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis—United States, 1985-1994. Morbidity and Mortality Weekly Report Center for Disease Control Surveillance Summary, 44(SS-4), 1-13.
7.
Crane, N. T., Wilson, D. B., Cook, A., Lewis, C. J., Yetley, E., & Rader, J. I. (1995). Evaluating food fortification options: General principles revisited with folic acid. American Journal of Public Health, 85, 660-666.
8.
Czeizel, A. E., & Dudas, I. (1992). Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New England Journal of Medicine, 327, 1832-1835.
9.
Daly, S., Mills, J. L., Molloy, A. M., Conley, M., Lee, Y. J., Kirke, P. N., et al. (1997). Minimum effective dose of folic acid for food fortification to prevent neural tube defects. Lancet, 350, 1666-1669.
10.
Fairfield, K. M., & Fletcher, R. H. (2002). Vitamins for chronic disease prevention in adults: Scientific review. Journal of the American Medical Association, 287(23), 3116-3126.
11.
Fletcher, R. H., & Fairfield, K. M. (2002). Vitamins for chronic disease prevention in adults: Clinical applications. Journal of the American Medical Association, 287(23), 3127-3129.
12.
Fox, S. A., Murata, P. J., & Stein, J. A. (1991). The impact of physician compliance on screening mammography for older women. Archives of Internal Medicine, 151, 50-56.
13.
Glanz, K., Lewis, F. M., & Rimer, B. K. (1997). Health behavior and health education: Theory, research and practice(2nd ed.). San Francisco: Jossey-Bass.
14.
Hammond, S., Volansky, M., Treiman, K., & Child, W. (1998, July). Folic acid and birth defects prevention: Focus group research with women at risk. Rockville, MD: Westat.
15.
Harnett, D. L. (1982). Statistical Methods(3rd ed.). Reading, MA: Addison-Wesley.
16.
Hochbaum, G. M. (1958). Public participation in medical screening programs: A sociopsychological study(Public Health Service Publication No. 572). Washington, DC: Government Printing Office.
17.
Institute of Medicine. (1998). Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline, pp.8-11. Washington, DC: National Academy Press.
18.
March of Dimes Birth Defects Foundation. (1999). Folic acid. White Plains, NY: Author.
19.
March of Dimes Birth Defects Foundation. (2000). Preparing for pregnancy IV: Fourth National Survey of Women’s Behavior and Knowledge Relative to Consumption of Folic Acid and Other Vitamins and Pre-Pregnancy Care. White Plains, NY: Author.
20.
March of Dimes Birth Defects Foundation. (2002). Folic acid and the prevention of birth defects: A National Survey of Pre-Pregnancy Awareness and Behavior Among Women of Childbearing Age, 1995-2001. Executive summary. White Plains, NY: Author.
21.
Medical Research Council Vitamin Study Research Group. (1991). Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet, 338, 131-137.
22.
Milunsky, A., Jick, H., Jick, S. S., Bruell, C. L., MacLaughlin, D. S., Rothman, K. J., et al. (1989). Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. Journal of the American Medical Association, 262, 2847-2852.
23.
Morbidity and Mortality Weekly Report. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity and Mortality Weekly Report, 41(RR-14), 1-7.
24.
Mulinare, J., Cordero, J. F., Erickson, J. D., & Berry, R. J. (1988). Periconceptional use of multivitamins and the occurrence of neural tube defects. Journal of the American Medical Association, 260, 3141-3145.
25.
Nallamothu, B. K., Fendrick, A. M., & Omenn, G. S. (2002). Homocyst(e)ine and coronary heart disease: Pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia. Pharmacoeconomics, 20(7), 429-442.
26.
National Center for Health Statistics. (1997). Births and deaths: United States, 1996. Monthly Vital Statistics Report, 46, 32-32.
27.
Pastuszak, A., Bhatia, D., Okotore, B., & Koren, G. (1999). The effectiveness of pre-conceptional counseling on women’s compliance with folic acid. In Maternal-fetal toxicity(3rd ed., pp. 2053-2057). New York: Marcel Dekker.
28.
Perelman, V., Signal, N., Einarson, A., Kennedy, D., & Koren, G. (1996). Knowledge and practice by Canadian family physicians regarding periconceptional folic acid supplementation for the prevention of neural tube defects. Canadian Journal of Clinical Pharmacology, 3, 145-148.
29.
Sadler, T. W. (1998). Mechanisms of neural tube closure and defects. Mental Retardation and Developmental Disabilities Research Reviews, 4, 247-253.
30.
Shaw, G. M., Schaffer, D., Velie, E. M., Morland, K., & Harris, J. A. (1995). Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects in California. Epidemiology, 6, 219-226.
31.
Smithells, R. W., Sheppard, S., Schorah, C. J., Sellar, M., Nevin, N. C., & Read, A. P., et al. (1980). Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet, 1, 339-340.
32.
U.S. Department of Health and Human Services, Public Health Service. (1995). Healthy People 2000: Midcourse review and 1995 revisions. Washington, DC: Government Printing Office.
33.
U.S. Public Health Service, Food and Drug Administration. (1996). Food additives permitted for direct addition to food for human consumption: Folic acid (folacin). Federal Register, 61, 8781-8797.
34.
Werler, M. M., Louik, C., & Mitchell, A. A. (1999). Achieving a public health recommendation for preventing neural tube defects with folic acid. American Journal of Public Health, 89(11), 1637-1640.
35.
Werler, M. M., Shapiro, S., & Mitchell, A. A. (1993). Periconceptional folic acid exposure and risk of occurrent neural tube defects. Journal of the American Medical Association, 269, 1257-1261.
